Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 21, 2023 $26.12 -3.27% $25.21 V 96.40% 1
Feb 21, 2023 $27.55 +2.04% $25.21 X 90.71% 0
Feb 21, 2023 Bullish $25.21 X 0
JS JS Pro
Jan 12, 2023 Bearish $34.06 V 0
JS JS Pro
Jan 12, 2023 Bullish $34.06 X 0
Jan 12, 2023 $34.33 -3.53% $34.06 V 99.20% 3
Jan 12, 2023 $34.80 -2.21% $34.06 V 97.81% 1
JS JS Pro
Oct 10, 2022 $41.43 +3.76% $36.32 X 85.93% 0
AlexVel AlexVel Pro
Oct 10, 2022 $38.71 -3.06% $36.32 V 93.42% 1
Oct 10, 2022 $42.19 +5.66% $36.32 X 83.84% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE